Cheri Gravalos

Director of Alliance, Management

Cheri Gravalos brings over 20 years of experience in business development and operations in life sciences, medical device, platform technologies, and clinical services. Mrs. Gravalos joined COI in 2014 and currently serves as Director of Alliance Management.

Prior to joining COI Mrs. Gravalos was Senior Advisor, Business Transformation, Life Sciences for Cisco System where she helped build transformative innovation for the life science industry. Additionally, she established a business development consulting practice, called C3, which facilitated small- and mid-cap companies with partnering, strategy, business planning, marketing, sales, startup activities and fundraising.

Mrs. Gravalos holds a M.B.A. in Business Management and Finance, and B.S. in Information Systems from San Diego State University-California State University.

in the news

  • Avalon Ventures and COI Pharmaceuticals Announce Acquisition of Sitari Pharmaceuticals by GSK

    read more
  • That’s a wrap on 2018…hello 2019!

    read more
  • Fortis Therapeutics Receives FDA Clearance of Two IND Applications for Novel Anti-CD46 Therapeutic for Treatment of Late-Stage Prostate Cancer and Multiple Myeloma

    read more